Nova Cell Technology Overview
- Founded
- 2000
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $9.1M
- Investors
- 3
Nova Cell Technology General Information
Description
Developer of biomaterials and pharmaceuticals intended to balance the immune system in a healthy way. The company's platform provides contract research services for new drug development as well as conducting collaborative research products with various other domestic and foreign universities, research labs, and institutions, enabling patients to cure diseases, such as atopy, asthma, dry eye disease, and inflammatory bowel disease .
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 77, Cheongam-ro, Nam-gu
- Pohang University of Science and Technology
- Pohang-si, Gyeongsangbuk-do
- South Korea
+82 000-000-0000
Nova Cell Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | $9.1M | 000.00 | Completed | Generating Revenue | ||
| 1. Early Stage VC | 28-Sep-2020 | 00.000 | 00.000 | Completed | Generating Revenue |
Nova Cell Technology Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Taehoon Lee Ph.D | Chief Executive Officer, Owner & President | ||
| Sunho Ki Ph.D | Chief Technology Officer |
Nova Cell Technology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| AION Partners (New York) | Real Estate | Minority | 000 0000 | 000000 0 | |
| Huons Global | Corporation | Minority | 000 0000 | 000000 0 | |
| Korea Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 |